|
Research
Dr.
Glodé's research has been clinically focused on prostate cancer for many years.
He headed the initial research on leuprolide, leading to it’s approval and
subsequently developed a “single shot” castration agent that is in animal
trials. He has also led efforts to evaluate a natural product, silibinin as a
preventive or therapeutic agent and has been an investigator on more than 30
clinical trials, including the PI position for the largest adjuvant trial in
prostate cancer, SWOG 9921. He has received numerous teaching awards and founded
the AACR course “Molecular Biology for Clinical Oncologists” as well as serving
as Founding Editor of the ASCO web site,
www.asco.org.
PUBLICATIONS:
BLOG:Thoughts and
updates about prostate cancer – written primarily for patients and their
families.
|
